Pediatric obstructive sleep apnea revisited: Perioperative considerations for the pediatric Anesthesiologist

Area of Science:

• Pediatric Sleep Medicine
• Neurology
• Otolaryngology

Background:

• Pediatric obstructive sleep apnea (OSA) affects up to 7% of children.
• OSA can lead to significant end-organ sequelae, including neurocognitive morbidity.
• Adenotonsillectomy (AT), the primary treatment for pediatric OSA, has not consistently shown efficacy in reducing all end-organ morbidities, particularly neurological and behavioral outcomes.

Purpose of the Study:

• To review the critical perioperative implications of OSA in children.
• To highlight the need for precise knowledge and planning for evidence-based practices in managing pediatric OSA.
• To discuss preoperative polysomnography, pharmacotherapeutics, and postoperative risk stratification for children with OSA.

Main Methods:

• Comprehensive literature review focusing on perioperative management of pediatric obstructive sleep apnea.
• Analysis of existing data on adenotonsillectomy outcomes and neurocognitive sequelae.
• Examination of preoperative assessment tools and postoperative risk stratification strategies.

Main Results:

• Adenotonsillectomy may not fully mitigate neurological and behavioral morbidities in children with OSA.
• Specific at-risk pediatric populations face heightened risks of neurocognitive impairment.
• Effective perioperative management requires detailed understanding of OSA's impact.

Conclusions:

• Optimal evidence-based care for pediatric OSA necessitates meticulous perioperative planning.
• Preoperative polysomnography, judicious pharmacotherapeutics, and careful postoperative risk stratification are essential.
• Further research is needed to improve long-term outcomes and reduce neurocognitive morbidity in children with OSA.